JATT Acquisition (JATT) Competitors $1.23 +0.08 (+6.96%) As of 04/17/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock JATT vs. HLVX, CRVO, CRDL, VXRT, ENTX, ADVM, VIGL, XCUR, RANI, and AVTEShould you be buying JATT Acquisition stock or one of its competitors? The main competitors of JATT Acquisition include HilleVax (HLVX), CervoMed (CRVO), Cardiol Therapeutics (CRDL), Vaxart (VXRT), Entera Bio (ENTX), Adverum Biotechnologies (ADVM), Vigil Neuroscience (VIGL), Exicure (XCUR), Rani Therapeutics (RANI), and Aerovate Therapeutics (AVTE). These companies are all part of the "pharmaceutical products" industry. JATT Acquisition vs. HilleVax CervoMed Cardiol Therapeutics Vaxart Entera Bio Adverum Biotechnologies Vigil Neuroscience Exicure Rani Therapeutics Aerovate Therapeutics JATT Acquisition (NYSE:JATT) and HilleVax (NASDAQ:HLVX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, valuation, institutional ownership, community ranking, analyst recommendations, earnings, risk, profitability and media sentiment. Do analysts rate JATT or HLVX? HilleVax has a consensus price target of $3.00, indicating a potential upside of 77.51%. Given HilleVax's stronger consensus rating and higher probable upside, analysts clearly believe HilleVax is more favorable than JATT Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score JATT Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00HilleVax 0 Sell rating(s) 6 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is JATT or HLVX more profitable? JATT Acquisition's return on equity of -49.58% beat HilleVax's return on equity.Company Net Margins Return on Equity Return on Assets JATT AcquisitionN/A -49.58% 2.84% HilleVax N/A -67.27%-51.99% Does the media prefer JATT or HLVX? In the previous week, JATT Acquisition's average media sentiment score of 0.00 equaled HilleVax'saverage media sentiment score. Company Overall Sentiment JATT Acquisition Neutral HilleVax Neutral Which has stronger earnings & valuation, JATT or HLVX? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioJATT AcquisitionN/AN/A$6.85MN/AN/AHilleVaxN/AN/A-$123.57M-$3.00-0.56 Do institutionals & insiders hold more shares of JATT or HLVX? 48.0% of JATT Acquisition shares are owned by institutional investors. Comparatively, 86.4% of HilleVax shares are owned by institutional investors. 20.0% of JATT Acquisition shares are owned by company insiders. Comparatively, 71.1% of HilleVax shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer JATT or HLVX? HilleVax received 10 more outperform votes than JATT Acquisition when rated by MarketBeat users. CompanyUnderperformOutperformJATT AcquisitionN/AN/AHilleVaxOutperform Votes1055.56% Underperform Votes844.44% SummaryHilleVax beats JATT Acquisition on 5 of the 8 factors compared between the two stocks. Get JATT Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for JATT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart JATT vs. The Competition Export to ExcelMetricJATT AcquisitionBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$21.22M$2.84B$5.31B$18.41BDividend YieldN/A1.86%5.45%4.18%P/E RatioN/A30.4821.9431.09Price / SalesN/A441.91380.9526.55Price / Cash27.08168.6838.2617.53Price / Book-2.323.466.454.30Net Income$6.85M-$72.06M$3.22B$1.02B1 Month Performance-7.52%-16.76%-9.76%-8.21%1 Year Performance-62.84%-26.05%11.49%1.69% JATT Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)JATTJATT AcquisitionN/A$1.23+7.0%N/A-62.8%$21.22MN/A0.003High Trading VolumeHLVXHilleVax2.1467 of 5 stars$1.54+5.5%$3.00+94.8%-86.3%$77.22MN/A-0.5020Gap DownCRVOCervoMed3.4442 of 5 stars$8.84+6.3%$27.50+211.1%-59.2%$76.94M$7.14M-4.354Short Interest ↓Gap UpCRDLCardiol Therapeutics1.8288 of 5 stars$0.92+11.6%$8.40+818.0%-42.9%$75.59MN/A-2.3520Analyst ForecastAnalyst RevisionNews CoverageGap UpVXRTVaxart1.3946 of 5 stars$0.33+7.6%$3.00+809.6%-54.5%$75.26M$28.70M-0.80120ENTXEntera Bio1.8158 of 5 stars$1.65+1.9%$10.00+505.9%-10.1%$74.97M$181,000.00-6.3520ADVMAdverum Biotechnologies3.7035 of 5 stars$3.58+5.3%$27.83+677.5%-74.2%$74.47M$1M-0.60190Earnings ReportAnalyst ForecastNews CoverageVIGLVigil Neuroscience2.7074 of 5 stars$1.49+6.4%$16.25+990.6%-39.4%$73.19MN/A-0.7240Gap DownXCURExicure1.7662 of 5 stars$11.50+1.0%N/A+1,404.5%$72.66M$500,000.00-5.5650Short Interest ↓News CoverageGap UpRANIRani Therapeutics1.6493 of 5 stars$1.26+18.9%$12.33+878.8%-83.5%$72.18M$1.03M-1.19110Gap UpAVTEAerovate Therapeutics0.8047 of 5 stars$2.49-0.8%$2.25-9.6%-87.5%$72.17MN/A-0.8320Gap Up Related Companies and Tools Related Companies HLVX Alternatives CRVO Alternatives CRDL Alternatives VXRT Alternatives ENTX Alternatives ADVM Alternatives VIGL Alternatives XCUR Alternatives RANI Alternatives AVTE Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:JATT) was last updated on 4/20/2025 by MarketBeat.com Staff From Our PartnersMy prediction is coming trueWe've developed a surprisingly effective way to see which stocks could double during massive shake-ups, by usi...InvestorPlace | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump to redistribute trillions of dollars Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredThe real reason gold is soaring (and likely to continue)Trump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | SponsoredElon Reveals Why There Soon Won’t Be Any Money For Social SecurityElon Musk's Near-Death Experience Sparks Dire Warning for Americans After cheating death twice—once in a te...Colonial Metals | SponsoredThe first casualty of the 2025 trade warThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredMusk’s AI Masterplan – Our #1 AI Stock to Buy NowDid Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...Behind the Markets | SponsoredClaim Your FREE Protection GuideIn the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding JATT Acquisition Corp Please log in to your account or sign up in order to add this asset to your watchlist. Share JATT Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy JATT Stock Free JATT Stock Alerts